The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers

International Clinical Psychopharmacology

Volumn 9, Issue 3, 1994, Pages 173-178

  Silverstone, P H ^a   Rue, J E ^a   Franklin, M ^a   Hallis, K ^a   Camplin, G ^a   Laver, D ^a   Cowen, P J ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

3 Methoxy 4 hydroxyphenyl glycerol; Adrenocorticotrophic hormone; Cortisol; Growth hormone; Hydroxytryptamine; m Chlorophenylpiperazine; Noradrenaline; Prolactin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; ALPHA ADRENERGIC RECEPTOR; CORTICOTROPIN; GROWTH HORMONE; HYDROCORTISONE; PLACEBO; PROLACTIN; SEROTONIN RECEPTOR;

ADULT; ANXIETY; ARTICLE; BLOOD PRESSURE; COGNITION; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AFFECT; ANXIETY; AROUSAL; BLOOD PRESSURE; COGNITION; CORTICOTROPIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; GROWTH HORMONE; HEART RATE; HORMONES; HUMAN; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; MALE; METHOXYHYDROXYPHENYLGLYCOL; PERSONALITY INVENTORY; PIPERAZINES; PROLACTIN; SEROTONIN AGONISTS;

EID: 0027999569     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/00004850-199409000-00005     Document Type: Article

References (27)

1. Bagdy G, Szemeredi K, Hill JL and Murphy DL (1989) Different serotonin receptors mediate blood-pressure, heart rate, plasma catecholamine and prolactin responses to m-ehlorophenylpip- erazine in conscious rats. Journal of Pharmacology and Experimental Therapeutics, 250, 72–78.
2. Charney DS, Woods SW, Goodman WK and Heninger GR (1987) Serotonin function in anxíety II: effects of the seroton in agoníst MCPP in panic disorder patients and healthy subjects. Psychopharmacology, 92, 14–24.
3. Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA and Heninger GR (1988) Serotonin function in obsessive- compulsive disorder: a comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Archives of General Psychiatry, 45, 177–185.
4. Davis BA (1989) Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects. Journal of Chromatography, 466, 89–218.
5. Done C, Silverstone PH and Sharp T (1992) Effect of naloxone- precipitated morphine-withdrawal on noradrenaline release in rat hippocampus in vivo. European Journal of Pharmacology, 215, 333–336.
6. Fuller RW, Snoddy HD, Mason NR and Owen JE (1981) Disposition and pharmacological effects of mCPP. Neuropharmacology, 20, 155–162.
7. Hamik A and Peroutka SJ (1989) I -(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. Biological Psychiatry, 25, 569–575.
8. Hollander E, DeCaría CM, Nitescu A, Gully R, Sickow RF, Cooper TB, Gorman JM, Klein DF and Liebowîtz MR (1992) Serotonergíc function in obsessive-compulsive disorder: behavioural and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Archives of General Psychiatry, 49, 21–28.
9. Jacobs D and Silverstone T (1986) Dextroamphetamìne-induced arousal in human subjects as a model for mania. Psychological Medicine. 16, 323–329.
10. Kalus O, Wetzler S, Kahn RS, Asnis GM and van Praag HM (1992) A dose-response study of intravenous m-chlorophenyl piperazine in normal subjects. Psychopharmacology, 106, 388–390.
11. Kennett GA, Whitton P, Shah K, Curzon G. (1989) Anxiogenic- like effects of m-CPP and TFMPP in animal models are opposed by 5-HT, receptor antagonists. European Journal of Pharmacology, 164,445–454.
12. Khan RS and Wetzler S (1991) m-chlorophenylpiperazine as a probe of serotonin function. Biological Psychiatry, 30, 1139–1166.
13. Khan RS, Kalus O, Wetzler S, Cahn W, Asnis GM and van Praag HM (1990a) Effects of serotonin antagonists on m-chloro- phenylpiperazine-mediated responses in normal subjects. Psychiatry Research, 33, 189–198.
14. Khan RS, Wetzler S, Asnis GM, Kling MA, Suckow RF and van Praag HM (1990b) Effects of m-chlorophenylpiperazinine normal subjects: a dose-response study. Psychopharmacology, 100, 339–344.
15. Lawlor BA, Sunderland T, Mellow AM, Hill JL, Newhouse PA and Murphy DL (1989) A preliminary study of the effects of intravenous m-chlorophenylpiperazine, a serotonin agonist, in elderly subjects. Biological Psychiatry, 25, 679–686.
16. Molyneux SG and Franklin M (1985) Routine determination of unconjugated 3-methoxy-4-hydroxyphenylglycol in plasma using high performance líquid chromatography with electrochemical detection. Journal of Chromatography, 341, 160–166.
17. Mueller EA, Murphy DL, Sunderland T and Jones J (1985a) A new postsynaptic serotonin receptor agonist suitable for studies in humans. Psychopharmacology Bulletin, 21, 701–704.
18. Mueller EA, Murphy DL and Sunderland T (1985b) Neuroendocrine effects of m-chlorophenylpiperazine, a serotonin agonist, in humans. Journal of Clinical Endocrinology and Metabolism, 61, 1179–1184.
19. Mueller EA, Murphy DL and Sunderland T (1986) Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology, 89, 388–391.
20. Murphy DL, Mueller EA, Hill JL, Tolliver TJ and Jacobsen FM (1989) Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology, 98, 275–282.
21. Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar- Kadouch RC and Murphy DL (1991) Metergoline blocks the behavioural and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder. Biological Psychiatry, 29, 418–426.
22. Seibyl JP, Krystal JH, Príce LH, Woods SW, D’Amico C, Heninger GR and Charney DS (1991) Effects of ritanserin on the behavioural, neuroendocrine, and cardiovascular responses to m-chlorophenylpiperazine in healthy human subjects. Psychiatry Research, 38, 227–236.
23. Silverstone PH and Cowen PJ (1994) The 5-HT, antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP) induced changes in human volunteers. Biological Psychiatry, in press.
24. Silverstone T and Turner P (1988) Drug Treatment in Psychiatry, 4th edn, pp. 25–27. Routledge, London.
25. Tuomisto J and Mannisto P (1985) Neurotransmitter regulation of anterior pituitary hormones. Pharmacological Reviews, 37, 249–332.
26. van Praag HM, Lemus CZ and Kahn RS (1987) Hormonal probes of serotonergic activity: do they really exist? Biological Psychiatry, 22, 86–89.
27. Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC and Murphy DL (1987) Serotonic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Archives of General Psychîatry, 44, 946–951.